drugset / Trial / NCT01937208

Comparable Study of Different Radiation Dose in Esophageal Carcinoma

NCT01937208 ↗

Phase 3 Unknown 300 enrolled Zhejiang Cancer Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Radiation therapy plus concurrent chemotherapy is now the standard therapy for patients with localized carcinoma of the esophagus selected for nonsurgical treatment. The standard radiation dose is 50-50.4Gy/1.8-2.0Gy/F.All of this were based on 2D radiation technology. Entering new century, 3D-CRT or IMRT has used on esophageal cancer. In China,the recommend radiation dose of concurrent chemoradiation was 60Gy. The study is a clinical phase III, randomized trial to compare the different radiation dose(60Gy vs 50Gy) of concurrent chemoradiation using 3D-CRT or IMRT in patients with unresectable esophageal carcinoma.

Timeline

Start
2013-08
Primary completion
2015-08
Completion
2017-07

Drugs

EvaluationDrugModalityDoseRoute
Background Cisplatin Other / unclassified 5 mg/m2 —
Background Cisplatin Other / unclassified 75 mg/m2 —
Background Docetaxel Small molecule 75 mg/m2 —